  See all
 |
Articles: Neuro/Psych pharmacology |
|
Receive free subspecialty "5-minute updates" via email
|
Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial
European Journal of Neurology, 11/23/09
Metabolic Alterations During Valproic Acid Treatment: A Prospective Study
Pediatric Neurology, 11/23/09 Review: Improving symptom control in early Parkinson's disease
Therapeutic Advances in Neurological Disorders, 11/23/09
Revew Article
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Archives of Neurology, 11/23/09
Evidence Based Medicine
Botulinum toxin type A in the healing of a chronic buttock ulcer in a patient with spastic paraplegia after spinal cord injury
Journal of Rehabilitation Medicine, 11/23/09 
Prior Articles
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Neurology, 11/20/09 Medication use is associated with fatigue in a sample of community-living individuals who have a spinal cord injury: a chart review
Spinal Cord, 11/20/09 Clinical utility of desvenlafaxine 50mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician
Current Medical Research and Opinion, 11/20/09 Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder
American Journal of Health-System Pharmacy, 11/20/09 Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs with pimavanserin, a 5-hydroxytryptamine2A receptor inverse agonist
Journal of Pharmacology and Experimental Therapeutics, 11/20/09 Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-stroke patients
Brain Injury, 11/19/09 The effect of statin therapy on the progression of carotid artery stenosis in relation to stenosis severity
Acta Neurologica Scandinavica, 11/19/09 Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-Release 10-mg tablets in patients with multiple sclerosis: A 2-week, open-label, follow-up study
Clinical Therapeutics, 11/19/09 Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: A phase I–II, open-label trial
Clinical Therapeutics, 11/19/09 Measuring apathy after traumatic brain injury: Psychometric properties of the Apathy Evaluation Scale and the Frontal Systems Behavior Scale
Brain Injury, 11/18/09 Effects of baclofen on motor units paralysed by chronic cervical spinal cord injury
Brain, 11/18/09 Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway
Multiple Sclerosis, 11/18/09 Mitoxantrone: benefits and risks in multiple sclerosis patients
Neurological Sciences, 11/18/09 Levodopa response in early Parkinsons disease
Movement Disorders, 11/18/09 Treatment of multiple sclerosis: role of natalizumab
Neurological Sciences, 11/18/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injury
more...
|
250 Available Pages
|
|
